Cargando…

Effect of acute and chronic exercise on plasma matrix metalloproteinase and total antioxidant levels

The relationship between acute and chronic exercise and expression of matrix metalloproteinases (MMPs) in muscles is unknown. There happen some alterations in the oxidant-antioxidant balance due to exercise. This study aimed to investigate the levels of MMP-1, tissue inhibitors of metalloproteinases...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tunc-Ata, Melek, Mergen-Dalyanoglu, Mukaddes, Turgut, Sebahat, Turgut, Günfer
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Society of Exercise Rehabilitation 2017
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5667596/ https://www.ncbi.nlm.nih.gov/pubmed/29114524 http://dx.doi.org/10.12965/jer.1735018.509

Ejemplares similares

Examination of levels pentraxin-3, interleukin-6, and C-reactive protein in rat model acute and chronic exercise
por: Tunc-Ata, Melek, et al.
Publicado: (2017)

Leptin Receptor Gene Polymorphism may Affect Subclinical Atherosclerosis in Patients with Acromegaly
por: Turgut, Sebahat, et al.
Publicado: (2016)

Association of Adipokines, Insulin Resistance, Hypertension and Dyslipidemia in Patients with Psoriasis Vulgaris
por: Coban, Melis, et al.
Publicado: (2016)

Plasma Levels of Matrix Metalloproteinase-9 in Children With Chronic Spontaneous Urticaria
por: Dilek, Fatih, et al.
Publicado: (2016)

Aluminium sulphate exposure increases oxidative stress and suppresses brain development in Ross broiler chicks
por: Oğuz, Emin Oğuzhan, et al.
Publicado: (2012)

Matrix metalloproteinases in exercise and obesity
por: Jaoude, Jonathan, et al.
Publicado: (2016)

Prolidase, Matrix Metalloproteinases 1 and 13 Activity, Oxidative-Antioxidative Status as a Marker of Preterm Premature Rupture of Membranes and Chorioamnionitis in Maternal Vaginal Washing Fluids
por: Soydinc, Hatice Ender, et al.
Publicado: (2013)

Association of Plasma Matrix Metalloproteinase and Tissue Inhibitors of Matrix Metalloproteinase Levels With Adverse Treatment Outcomes Among Patients With Pulmonary Tuberculosis
por: Kumar, Nathella P., et al.
Publicado: (2020)

Elevated Plasma Levels of Matrix Metalloproteinase-3 and Tissue-Inhibitor of Matrix Metalloproteinases-1 Associate With Organ Dysfunction and Mortality in Sepsis
por: Jones, Tiffanie K., et al.
Publicado: (2022)

Helminth Coinfection Is Associated With Enhanced Plasma Levels of Matrix Metalloproteinases and Tissue Inhibitor of Metalloproteinases in Tuberculous Lymphadenitis
por: Kathamuthu, Gokul Raj, et al.
Publicado: (2021)

Plasma levels of matrix metalloproteinase-9 are elevated in individuals with hypertensive crisis
por: Valente, Flavia Mariana, et al.
Publicado: (2020)

Genetic variations and plasma levels of gelatinase A (matrix metalloproteinase-2) and gelatinase B (matrix metalloproteinase-9) in proliferative diabetic retinopathy
por: Beránek, Michal, et al.
Publicado: (2008)

Salivary and plasma levels of matrix metalloproteinase-9 and myeloperoxidase at rest and after acute physical exercise in patients with coronary artery disease
por: Mahmood, Zeid, et al.
Publicado: (2019)

Plasma Matrix Metalloproteinase-9 and Tissue Inhibitor of Matrix Metalloproteinase-1 as Prognostic Biomarkers in Critically Ill Patients
por: Duda, Izabela, et al.
Publicado: (2020)

Matrix metalloproteinase and tissue inhibitor of metalloproteinase responses to muscle damage after eccentric exercise
por: Kim, Jooyoung, et al.
Publicado: (2016)

Plasma Levels of Matrix Metalloproteinases 2 and 9 in Patients with Chronic Chagas Heart Disease and Systemic Arterial Hypertension: Correlation with TGF-Beta Plasma Levels
por: Bestetti, Reinaldo B., et al.
Publicado: (2023)

The Association Among Lipoprotein-associated Phospholipase A2 Levels, Total Antioxidant Capacity and Arousal in Male Patients with OSA
por: Bekci, Taha T., et al.
Publicado: (2011)

Oxidative Stress and Benefits of Antioxidant Agents in Acute and Chronic Hepatitis
por: Esrefoglu, Mukaddes
Publicado: (2012)

Matrix Metalloproteinases in Chronic Obstructive Pulmonary Disease
por: Christopoulou, Maria-Elpida, et al.
Publicado: (2023)

Does Cardiovascular Disease Risk Decrease after Smoking Cessation in Occupational Risk Groups?
por: Bozkurt, Nurgül, et al.
Publicado: (2022)

Levels of matrix metalloproteinases differ in plasma and serum – aspects regarding analysis of biological markers in cancer
por: Jonsson, Andreas, et al.
Publicado: (2016)

Relationship between plasma matrix metalloproteinase levels, pulmonary function, bronchodilator response, and emphysema severity
por: Koo, Hyeon-Kyoung, et al.
Publicado: (2016)

Correlation Between Plasma Matrix Metalloproteinase-28 Levels and Severity of Calcific Aortic Valve Stenosis
por: Zhou, Ke, et al.
Publicado: (2020)

Plasma levels of matrix metalloproteinase‐9 (MMP‐9) are associated with cognitive performance in patients with schizophrenia
por: Kudo, Noriko, et al.
Publicado: (2020)

Correlation of matrix metalloproteinase 3 and matrix metalloproteinase 9 levels with non-motor symptoms in patients with Parkinson’s disease
por: Liu, Chuan Ze, et al.
Publicado: (2022)

Healing of External Inflammatory Root Resorptions and Periapical Lesions without Surgical Treatment in an Operated Oblique Facial Cleft Case
por: Canoglu, Ebru, et al.
Publicado: (2010)

Expression of tissue levels of matrix metalloproteinases and tissue inhibitors of metalloproteinases in renal cell carcinoma
por: Qiao, Zhen-kui, et al.
Publicado: (2013)

Expression of Matrix Metalloproteinase-2, Matrix Metalloproteinase-9, Tissue Inhibitor of Metalloproteinase-1, and Changes in Alveolar Septa in Patients with Chronic Obstructive Pulmonary Disease
por: Zhang, Yongxiang, et al.
Publicado: (2020)

Functional relationship between matrix metalloproteinase-11 and matrix metalloproteinase-14
por: Buache, Emilie, et al.
Publicado: (2014)

Expression of matrix metalloproteinases and tissue inhibitor of matrix metalloproteinases in the hair cycle
por: HOU, CHUN, et al.
Publicado: (2016)

Plasma Levels of Matrix Metalloproteinase (MMP)-2, MMP-9 and Tumor Necrosis Factor-α in Chronic Hepatitis C Virus Patients
por: Abdel-Latif, Mohamed S
Publicado: (2015)

Matrix metalloproteinase-9, -10, and tissue inhibitor of matrix metalloproteinases-1 blood levels as biomarkers of severity and mortality in sepsis
por: Lorente, Leonardo, et al.
Publicado: (2009)

Plasma levels of the tissue inhibitor matrix metalloproteinase-3 as a potential biomarker in oral cancer progression
por: Su, Chun-Wen, et al.
Publicado: (2017)

Acute Exercise Increases Plasma Total Antioxidant Status and Antioxidant Enzyme Activities in Untrained Men
por: Berzosa, C., et al.
Publicado: (2011)

Plasma matrix metalloproteinases in neonates having surgery for congenital heart disease
por: Joffe, Ari R., et al.
Publicado: (2009)

Matrix metalloproteinases and epileptogenesis
por: Ikonomidou, Chrysanthy
Publicado: (2014)

Matrix Metalloproteinases and Glaucoma
por: Kim, Moo Hyun, et al.
Publicado: (2022)

Plasma Levels and Diagnostic Utility of Macrophage Colony-Stimulating Factor, Matrix Metalloproteinase-9, and Tissue Inhibitor of Metalloproteinases-1 as New Biomarkers of Breast Cancer
por: Ławicki, Sławomir, et al.
Publicado: (2016)

Exercise-induced responses in matrix metalloproteinases and osteopontin are not moderated by exercise format in males with overweight or obesity
por: Raman, Aaron, et al.
Publicado: (2023)

Differential Expression of Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases in Thioacetamide-Induced Chronic Liver Injury
por: Park, Soo Young, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_147g7j2vfvc4sau9llr38l7uce